<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>RUNX1/AML1 point mutations have been identified in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>A heterozygous germline mutation of the RUNX1 gene causes a familial <z:e sem="disease" ids="C0005818" disease_type="Disease or Syndrome" abbrv="">platelet disorder</z:e> with a predisposition to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>RUNX1 mutations have also been detected with high frequency in minimally differentiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M0 subtypes and myelodysplastic/myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we propose a new disease category of myelodysplastic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (MDN) consisting of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>-related changes, including therapy-related cases </plain></SENT>
<SENT sid="4" pm="."><plain>RUNX1 mutations have been detected in about 20% of patients with "MDN" </plain></SENT>
<SENT sid="5" pm="."><plain>Among the MDN cases, histories of radiation exposure, therapy-related myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> after successful treatment for <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo>, and leukemic transformation of myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> have been reported to have a strong association with RUNX1 mutations </plain></SENT>
<SENT sid="6" pm="."><plain>The mutations occur in a <z:mpath ids='MPATH_458'>normal</z:mpath>, a receptive, or a disease-committed hematopoietic stem cell </plain></SENT>
<SENT sid="7" pm="."><plain>It is suspected that the "MDN" phenotypes are defined by the RUNX1 mutations in addition to some other abnormalities </plain></SENT>
</text></document>